Summary
Richard Perryman is a laboratory manager and post-doctoral cancer metabolism researcher with 16 years’ experience translating metabolic biology into pre-clinical glioma therapies. Based at Imperial College London, he has led projects on arginine deprivation, NAD biosynthesis inhibition and ketogenic dietary approaches while developing PIL A/B/C-certified glioma models and guiding trainees from undergraduate to clinical degrees. His skillset spans cancer stem cell biology, molecular techniques, metabolic assays and multi-omics bioinformatics in R, combined with hands-on lab management and high-throughput genetics experience from earlier GWAS work. Meticulous and self-motivated, he focuses on translational discoveries with clear paths to improve patient outcomes and a track record of supervising diverse research programs.
16 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Neuro-oncology and cancer metabolism, Doctor of Philosophy (Ph.D.), Neuro-oncology and cancer metabolism at Imperial College London
Bachelor’s Degree, Medical Sciences, First Class (Hons), Bachelor’s Degree, Medical Sciences, First Class (Hons) at University of Exeter
English